ArticlePCN reports : psychiatry and clinical neurosciences2025

Cost-effectiveness analysis of pharmacogenetic-guided antiseizure medication therapy based on the risk of HLA-A*31:01 allele variants in Japan.

Yasushi Maruyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.